[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100616757":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":7,"responsibleParty":17,"collaborators":7,"id":21,"slug":22,"hasResults":23,"nctId":24,"briefTitle":25,"officialTitle":25,"acronym":7,"eligibilityCriteria":26,"healthyVolunteers":23,"sex":27,"minAge":28,"maxAge":29,"enrollmentInfo":30,"targetDuration":7,"studyType":33,"phases":7,"briefSummary":34,"conditions":35,"keywords":37,"overallStatus":41,"whyStopped":7,"lastUpdateSubmitDate":42,"lastUpdatePostDateStruct":43,"startDateStruct":46,"completionDateStruct":48,"leadSponsor":50,"locationsCount":7},{"fullName":5,"class":6},"Oregon Health and Science University","OTHER",null,[9,14],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Evan Shalen, MD","CONTACT","503-494-1775","shalen@ohsu.edu",{"name":15,"role":11,"phone":7,"phoneExt":7,"email":16},"Sara McCrimmon","mccrimmo@ohsu.edu",{"type":18,"investigatorFullName":19,"investigatorTitle":20,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Evan Shalen","Assistant Professor","100616757","maternal-outcomes-with-methamphetamine-use-and-cardiac-assessment-for-rural-dissemination-mom-card-100616757",false,"NCT07309757","Maternal Outcomes With Methamphetamine Use and Cardiac Assessment for Rural Dissemination (MOM CARD)","Inclusion Criteria:\n\n* 18 years or older \\> 20 weeks gestation admitted to the hospital\n* Active patient-defined regular methamphetamine use for at least 1 year and any use within the last month\n* Able to understand and provide informed consent\n* Able to understand English\n\nExclusion Criteria:\n\nThese criteria will exclude women whose medications, personal traits, obstetric conditions, or diseases could confound cardiovascular risk.\n\n* Prescribed stimulants\n* Echocardiogram or EKG previously performed during current pregnancy\n* Previous diagnosis of congestive heart dysfunction\n* Previous diagnosis of pulmonary hypertension\n* Previous myocardial infarction\n* Previous diagnosis of endocarditis\n* Prior cardiac intervention (repair of cardiac congenital lesion, valve replacement or repairs, percutaneous\u002Foperative treatment of arrhythmias)\n* High-risk aortopathy (Marfan syndrome, bicuspid aortopathy, prior aortic dissection)","FEMALE","18 Years","65 Years",{"count":31,"type":32},35,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to develop a pilot screening protocol, comparing cardiac point-of-care ultrasound (POCUS), electrocardiogram (EKG), serum biomarkers (N-terminal pro b-type natriuretic peptide (NT-proBNP), high sensitivity troponin (hsTn)) with formal transthoracic echocardiogram (TTE) in pregnant women with methamphetamine use.",[36],"Methamphetamine Abuse",[38,39,40],"Methamphetamine use","Pregnancy","Cardiomyopathy","NOT_YET_RECRUITING","2025-12-29",{"date":44,"type":45},"2026-01-02","ACTUAL",{"date":47,"type":32},"2026-02-01",{"date":49,"type":32},"2027-12-31",{"name":5,"class":6}]